Among genes including APC, RAS, BRAFV600E, and TP53, our analysis showed that the coexistence of TP53 and SMAD4 mutation was associated with a significantly worse prognosis in patients with metastatic colorectal cancer. Here, SMAD4 is linked to metastatic colorectal cancer.